eSight Corporation
Developer of a wearable digital low-vision device that captures and processes a user’s field of view in real time and presents enhanced video via near‑eye displays. The company integrates high-speed imaging hardware, real-time image enhancement software, near‑to‑eye displays, and remote training/telehealth services. Devices are clinically validated, registered as medical devices in multiple jurisdictions, and manufactured under contract in the United States.
Industries
N/A
Nr. of Employees
small (1-50)
eSight Corporation
Gentex Corporation, 600 North Centennial Street, Zeeland, MI 49464, USA
Products
Wearable digital low-vision device
Lightweight, glasses‑style wearable system that captures a user’s field of view with a high-resolution camera, enhances the image in real time, and presents it on near‑eye displays to improve central vision tasks.
Wearable digital low-vision device
Lightweight, glasses‑style wearable system that captures a user’s field of view with a high-resolution camera, enhances the image in real time, and presents it on near‑eye displays to improve central vision tasks.
Services
Short-term in-home trial that ships a demo device for a 7-day evaluation and includes virtual training; trial fees may apply and can be applied toward purchase.
Video-conferencing based training and rehabilitation sessions delivered by coaches with lived low-vision experience to support device setup and skill acquisition.
Regional distributor channel providing sales, in‑home or in‑office demonstrations and coordination with local providers and benefits offices.
Web-based screening quiz and appointment scheduling to assess candidate suitability for device trials and consultations with specialists.
Condition-specific educational materials covering vision loss types, signs and symptoms, prevention strategies, diagnosis, and treatment options for patients and clinicians.
Short-term in-home trial that ships a demo device for a 7-day evaluation and includes virtual training; trial fees may apply and can be applied toward purchase.
Video-conferencing based training and rehabilitation sessions delivered by coaches with lived low-vision experience to support device setup and skill acquisition.
Regional distributor channel providing sales, in‑home or in‑office demonstrations and coordination with local providers and benefits offices.
Web-based screening quiz and appointment scheduling to assess candidate suitability for device trials and consultations with specialists.
Condition-specific educational materials covering vision loss types, signs and symptoms, prevention strategies, diagnosis, and treatment options for patients and clinicians.
Expertise Areas
- Wearable assistive vision systems
- Real-time image enhancement algorithms
- Telehealth-based vision rehabilitation
- Clinical study design and multicenter validation
Key Technologies
- High-speed high-resolution camera modules
- Real-time image processing and enhancement algorithms
- Autofocus and image stabilization methods
- High-brightness near-eye OLED displays
News & Updates
Published multicenter prospective study reporting improvements such as a seven-line gain in distance acuity, 12-letter contrast improvement and retention of mobility outcomes (ClinicalTrials.gov Identifier NCT02616900).
Recognized by CNN as one of 11 life-changing assistive technologies.
Included in Time magazine’s list of 25 Best Inventions.
Multiple awards including Health Tech Digital Awards (Best Wearable Technology Solution, 2019) and Golden Bridge Awards (Work-from-Home Implementation, 2020).
Published multicenter prospective study reporting improvements such as a seven-line gain in distance acuity, 12-letter contrast improvement and retention of mobility outcomes (ClinicalTrials.gov Identifier NCT02616900).
Recognized by CNN as one of 11 life-changing assistive technologies.
Included in Time magazine’s list of 25 Best Inventions.
Multiple awards including Health Tech Digital Awards (Best Wearable Technology Solution, 2019) and Golden Bridge Awards (Work-from-Home Implementation, 2020).